# A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD

> **NCT01163786** · PHASE2 · TERMINATED · sponsor: **Northwestern University** · enrollment: 17 (actual)

## Conditions studied

- Bronchiolitis Obliterans

## Interventions

- **DRUG:** Bortezomib

## Key facts

- **NCT ID:** NCT01163786
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10-07
- **Primary completion:** 2015-09-09
- **Final completion:** 2015-09-09
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Study was closed due to low accrual before the accrual goal was reached
- **Last updated:** 2020-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01163786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01163786, "A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01163786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*